Document

Filter documents Clear search

pdf icon

FSRH CEU Statement: Contraception for Women with Eating Disorders (May 2021)

File size: 566kb | Date: 10 May 2021 | Clinical Statements - PDF

Sexually active women of reproductive age with eating disorders require effective contraception despite the fact that amenorrhoea and anovulation are common in this population. This statement provides clinicians with a resource for best helping women with eating disorders choose the most appropriate and acceptable contraception for them. Download and save the document here.

pdf icon

FSRH CEU statement Levosert 6 year license for contraception - Feb 2021

File size: 378kb | Date: 8 February 2021 | Clinical Statements - PDF

This statement notes that the Levosert® 52mg LNG-IUS has been licensed for contraceptive use for 6 years. Levosert remains licensed for 5 years for management of heavy menstrual bleeding and is not licensed for endometrial protection as part of HRT.

pdf icon

FSRH CEU Statement: Response to recently published “Bridge-It” study by Cameron, et al - November 2020

File size: 209kb | Date: 23 November 2020 | Clinical Statements - PDF

The FSRH CEU summarizes and comments on the Cameron, et al “Bridge-It” study, which found that women receiving levonorgestrel emergency contraception from a pharmacy are more likely to be using effective ongoing contraception if they are given a three-month supply of progestogen-only pill and facilitated access to local SRH services.

pdf icon

FSRH CEU Statement: Response to Recent Publication Regarding Banh, et al - November 2020

File size: 233kb | Date: 17 November 2020 | Clinical Statements - PDF

“The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing three pills and taking ulipristal acetate 30 mg” The journal Contraception recently published a study investigating timing of combined oral contraceptive pill (COC) restart after missed pills and use of ulipristal acetate emergency contraception (UPA-EC). The FSRH CEU responds to this study and advises where guidance does—and does not—change.